知镜 Cognispect · 医学文献与研究工作台

Decoding the role of cancer-associated fibroblasts in cisplatin resistance of head and neck squamous cell carcinoma.

Liu D, Yu D, Chen M, Dai T, Li X, Su D, Zheng J, Zhang Y.
iScience · 2026-09-22 · PMID 42894773

文献摘要

Cisplatin remains the primary chemotherapy drug for the treatment of head and neck squamous cell carcinoma (HNSCC). However, acquired resistance significantly limits its clinical application, contributing to treatment failure and a poor patient prognosis. Cancer-associated fibroblasts (CAFs) in the tumor microenvironment influence HNSCC sensitivity to cisplatin by modulating tumor cell responsiveness to treatment via paracrine signaling. CAFs impede deep penetration into tumors by remodeling the extracellular matrix (ECM). Various subtypes of cisplatin-resistant CAFs have been identified in HNSCC. Potential compounds targeting these subtypes could enhance cisplatin sensitivity. Simulation of the dynamic tumor microenvironment remains limited in research, hindering clinical translation. Bioinformatics has shifted research into cisplatin resistance in HNSCC. Single-cell sequencing and spatiotemporal transcriptomics could analyze the molecular profiles of CAFs that promote drug resistance in greater depth, potentially facilitating the development of highly targeted drugs and effective combination therapy strategies to overcome cisplatin resistance in HNSCCs.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。